Related Experiment Video

Updated: May 8, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Inhibition of Plk1 and Cyclin B1 expression results in panobinostat-induced G₂ delay and mitotic defects

Michael Prystowsky1, Katherine Feeney, Nicole Kawachi

  • 1Department of Pathology, Albert Einstein College of Medicine and Montefiore Medical Center, USA.

Scientific Reports
|September 13, 2013
PubMed

Insights

Panobinostat causes a G₂ cell cycle delay and mitotic defects in human head and neck squamous cell carcinoma (HNSCC) cells. This histone deacetylase inhibitor shows potential as a chemotherapeutic for HNSCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Histone deacetylase inhibitors (HDACi) are emerging as promising cancer therapeutics.
  • Panobinostat (LBH589) is an HDACi with preclinical activity against various cancers.
  • The precise mechanisms of panobinostat's effects on head and neck squamous cell carcinoma (HNSCC) require further elucidation.

Purpose of the Study:

  • To investigate the mechanistic basis of panobinostat-induced growth arrest in HNSCC cell lines.
  • To analyze the effects of panobinostat on cell cycle progression, particularly during mitosis.

Main Methods:

  • Synchronized HNSCC cell lines were treated with panobinostat.
  • Mitotic progression was monitored using various cell biology techniques.
  • Gene expression and protein levels (Plk1, Cyclin B1, p21Waf1/Cip1) were analyzed.
  • Chromatin immunoprecipitation was used to assess transcription factor recruitment (E2F1).

Main Results:

  • Panobinostat induced a significant G₂ cell cycle delay and observable mitotic defects.
  • A decrease in G₂-specific gene expression (Plk1, Cyclin B1) and an increase in p21Waf1/Cip1 were observed.
  • Panobinostat treatment resulted in reduced E2F1 binding to the promoters of key cell cycle genes.

Conclusions:

  • Panobinostat effectively causes cell cycle arrest at the G₂/M phase in HNSCC cells through modulation of key cell cycle regulators.
  • These findings provide mechanistic insight into panobinostat's anti-cancer activity and support its potential as a therapeutic agent for HNSCC.

More Related Videos

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.